Long-term neuro-functional disability in adult patients with community-acquired bacterial meningitis
- PMID: 35657529
- DOI: 10.1007/s15010-022-01855-2
Long-term neuro-functional disability in adult patients with community-acquired bacterial meningitis
Abstract
Purpose: To investigate the prevalence of neuro-functional disability and its determinants 12 months after community-acquired bacterial meningitis (CABM) in adult patients.
Methods: In a prospective multicenter cohort study (COMBAT), all consecutive cases of CABM were enrolled and followed up for 12 months. Neuro-functional disability at 12 months was evaluated using a combination of the Glasgow Outcome Scale (functional disability), and the modified Rankin Disability Scale (physical disability). Factors associated with neuro-functional disability were identified by multivariate logistic regression.
Results: Among 281 patients, 84 (29.9%) patients exhibited neuro-functional disability at 12 months: 79 (28.1%) with functional disability and 51 (18.1%) with physical disability. Overall, 6 patients (2.1%) died during the follow-up. The most common pathogen identified was Streptococcus pneumoniae (131/272, 48.2%); 77/268 patients (28.7%) had a physical disability at hospital discharge. Factors independently associated with 12-month neuro-functional disability were a pneumococcal meningitis (adjusted OR = 2.8; 95% confidence interval (CI) = [1.3; 6.7]), the presence of a physical disability at hospital discharge (aOR = 2.3; 95%CI = [1.2; 4.4]) and the presence of behavioral disorders at hospital-discharge (aOR = 5.9; 95%CI = [1.6; 28.4]). Dexamethasone use was not significantly associated with neuro-functional disability (OR = 0.2; 95%CI = [< 0.1;1.3]).
Conclusion: Neuro-functional disability is frequently reported 12 months after CABM. Detailed neurological examination at discharge is needed to improve the follow-up.
Trial registration: NCT01730690.
Keywords: Bacterial meningitidis; Cohort study; Functional disability; Neuro-functional disability; Physical disability.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
References
-
- van de Beek D, Brouwer MC, Koedel U, Wall EC. Community-acquired bacterial meningitis. The Lancet. 2021;398:1171–83. https://doi.org/10.1016/S0140-6736(21)00883-7 . - DOI
-
- Bijlsma MW, Brouwer MC, Kasanmoentalib ES, Kloek AT, Lucas MJ, Tanck MW, et al. Community-acquired bacterial meningitis in adults in the Netherlands, 2006–14: a prospective cohort study. Lancet Infect Dis. 2016;16:339–47. https://doi.org/10.1016/S1473-3099(15)00430-2 . - DOI - PubMed
-
- Lucas MJ, Brouwer MC, van de Beek D. Neurological sequelae of bacterial meningitis. J Infect. 2016;73:18–27. https://doi.org/10.1016/j.jinf.2016.04.009 . - DOI - PubMed
-
- Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1:480–4. https://doi.org/10.1016/s0140-6736(75)92830-5 . - DOI - PubMed
-
- Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma. 1998;15:573–85. https://doi.org/10.1089/neu.1998.15.573 . - DOI - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
